dc.contributor.author | Blanchard, Joel W. | |
dc.contributor.author | Tsai, Li-Huei | |
dc.contributor.author | Blanchard, Joel W. | |
dc.date.accessioned | 2019-11-15T16:56:27Z | |
dc.date.available | 2019-11-15T16:56:27Z | |
dc.date.issued | 2019-03 | |
dc.identifier.issn | 1934-5909 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/122952 | |
dc.description.abstract | Conflicting clinical studies have reported that statins both reduce and accelerate cognitive impairments in Alzheimer’s disease. In this issue, Van der Kant et al. (2019) use iPSC-derived neurons to thoroughly dissect the link between cholesterol synthesis, phospho-Tau, and amyloid-β, revealing new therapeutic opportunities in Alzheimer’s disease and related dementias. | en_US |
dc.publisher | Elsevier BV | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1016/j.stem.2019.02.003 | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-NoDerivs License | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
dc.source | Prof. Tsai via Courtney Crummett | en_US |
dc.title | Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer’s Disease | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Blanchard, Joel W. and Tsai, Li-Huei. "Unraveling the Paradox of Statins with Human Neurons: New Leads in Alzheimer’s Disease." Cell Stem Cell 24, 3 (March 2019): 347-349 © 2019 Elsevier | en_US |
dc.contributor.department | Picower Institute for Learning and Memory | en_US |
dc.relation.journal | Cell Stem Cell | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.date.submission | 2019-11-04T20:20:43Z | |
mit.journal.volume | 24 | en_US |
mit.journal.issue | 3 | en_US |
mit.license | OPEN_ACCESS_POLICY | |